What you should know:
1. Much is still unknown about how IBD interacts with cancer treatments and the resulting side effects; however, current research has found connections.
A study published in European Urology found IBD patients were more likely to develop prostate cancer compared to a control group, with risk increasing as patients aged. Another study suggested IBD patients faced a three times greater risk of developing papillary thyroid cancer compared to a control group.
2. Findings reported at the American College of Cardiology’s 2018 annual meeting March 10-12 in Orlando, Fla., found IBD patients had an elevated risk of myocardial infarction than a control group, with young female patients at the greatest risk.
3. MedPage also reports IBD patients were at greater risk for Parkinson’s disease and immune-mediated diseases.
Ashwin N. Ananthakrishnan, MD, of Boston-based Massachusetts General Hospital said to MedPage: “A larger number of older IBD patients are at risk for different comorbidities just because of their age, and this is an important consideration in treatment. Cancer, chronic obstructive pulmonary disease, cardiovascular disease and diabetes are the most relevant and common comorbidities that challenge the management of IBD patients.”
Read the entire MedPage article here.
More articles on gastroenterology:
How surveillance affects hand hygiene compliance
3 ways to improve ASC quality
ASC-specific data collection essential in developing industry quality measures, study finds
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
